Rhenman & Partners Asset Management Ab Zimmer Biomet Holdings, Inc. Transaction History

Rhenman & Partners Asset Management Ab

$1.2 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$119.98 - $132.61 $1.5 Million - $1.66 Million	12,500 Added 22.73%	67,500 $8.91 Million
Q4 2023 Feb 13, 2024	SELL	$102.72 - $121.7 $513,600 - $608,500	-5,000 Reduced 8.33%	55,000 $6.69 Million
Q3 2023 Nov 13, 2023	SELL	$110.76 - $143.18 $18.3 Million - $23.6 Million	-165,000 Reduced 73.33%	60,000 $6.73 Million
Q3 2023 Nov 09, 2023	BUY	$110.76 - $143.18 $9.64 Million - $12.5 Million	87,000 Added 63.04%	225,000 $25.2 Million
Q2 2023 Aug 11, 2023	BUY	$126.43 - $145.6 $17.4 Million - $20.1 Million	138,000 New	138,000 $20.1 Million
Q1 2022 May 13, 2022	SELL	$108.42 - $129.58 $9.76 Million - $11.7 Million	-90,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$115.43 - $146.63 $3.46 Million - $4.4 Million	-30,000 Reduced 25.0%	90,000 $11.5 Million
Q3 2021 Nov 12, 2021	SELL	$136.35 - $158.76 $2.73 Million - $3.18 Million	-20,000 Reduced 14.29%	120,000 $17.6 Million
Q2 2021 Aug 13, 2021	BUY	$152.95 - $173.41 $1.53 Million - $1.73 Million	10,000 Added 7.69%	140,000 $22.5 Million
Q1 2021 May 14, 2021	BUY	$148.16 - $159.71 $9.63 Million - $10.4 Million	65,000 Added 100.0%	130,000 $20.8 Million
Q4 2020 Jan 19, 2021	SELL	$128.25 - $151.41 $2.18 Million - $2.57 Million	-17,000 Reduced 20.73%	65,000 $10 Million
Q3 2020 Oct 13, 2020	BUY	$113.59 - $141.68 $2.84 Million - $3.54 Million	25,000 Added 43.86%	82,000 $11.2 Million
Q2 2020 Jul 16, 2020	SELL	$87.02 - $133.4 $2 Million - $3.07 Million	-23,000 Reduced 28.75%	57,000 $6.8 Million
Q1 2020 Apr 16, 2020	BUY	$78.28 - $155.73 $6.26 Million - $12.5 Million	80,000 New	80,000 $8.09 Million

Others Institutions Holding ZBH

# of Institutions

1,079

Shares Held

178M

Call Options Held

301K

Put Options Held

View Full List

About ZIMMER BIOMET HOLDINGS, INC.

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $22.4B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

More about ZBH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account